MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.jacc.2025.01.013

Медицинская библиотека · Journal of the American College of Cardiology · 2025

Bioprosthetic vs Mechanical Aortic Valve Replacement in Patients 40 to 75 Years of Age.

Bowdish Michael E, Mehaffey J Hunter, Chang Shu-Ching, O'Gara Patrick T, Mack Michael J, Goldstone Andrew B, Chikwe Joanna, Gillinov A Marc, Wu Changfu, Fontana Gregory P, Bavaria Joseph E, Malaisrie Chris S, Kaneko Tsuyoshi, Sultan Ibrahim S, Wyler von Ballmoos Moritz C, Harrington Kathrine B, Jacobs Jeffrey P, Thourani Vinod H, Szeto Wilson Y, Sabik Joseph F, Habib Robert H, Badhwar Vinay

СтатьяСравнительное исследованиеПеревод пока не подготовлен

Аннотация

BACKGROUND

The choice of bioprosthetic or mechanical surgical aortic valve replacement (AVR) should balance individual valve durability with the potential liabilities of oral anticoagulation.

OBJECTIVES

To inform clinical practice, this study sought to evaluate contemporary, real-world, long-term AVR outcomes from the Society of Thoracic Surgeons Adult Cardiac Surgery Database (STS ACSD).

METHODS

All patients undergoing primary isolated bioprosthetic or mechanical AVR were identified. Patients aged <40 and >75 years with endocarditis, emergency/salvage status, shock, ejection fraction ≤25%, and any prior cardiac surgery were excluded. Validated methodology was applied for linkage to the National Death Index to define longitudinal all-cause mortality (2008-2019). Robust risk adjustment was performed by using age-specific inverse probability weighting and restricted cubic splines to model nonlinear age relationships. Sensitivity analyses excluded pure aortic insufficiency, intermediate/high risk (STS predicted risk of operative mortality >4%), and discontinued valve types.

RESULTS

A total of 109,842 patients underwent bioprosthetic (n = 94,125) or mechanical (n = 15,717) AVR during the study period. After risk adjustment, freedom from all-cause mortality favored mechanical valves in patients aged 60 years and younger. Age group-specific analyses showed that mechanical valves were associated with lower all-cause mortality in all age groups ≤60 years. These results remained consistent across all sensitivity analyses.

CONCLUSIONS

In patients aged ≤60 years, mechanical AVR was associated with an independent risk-adjusted survival benefit compared with bioprosthetic AVR. These contemporary 12-year survival data further inform patient and provider shared clinical decision-making regarding prosthetic aortic valves.

Для цитирования: Bowdish Michael E, Mehaffey J Hunter, Chang Shu-Ching, O'Gara Patrick T, Mack Michael J, Goldstone Andrew B, Chikwe Joanna, Gillinov A Marc, Wu Changfu, Fontana Gregory P, Bavaria Joseph E, Malaisrie Chris S, Kaneko Tsuyoshi, Sultan Ibrahim S, Wyler von Ballmoos Moritz C, Harrington Kathrine B, Jacobs Jeffrey P, Thourani Vinod H, Szeto Wilson Y, Sabik Joseph F, Habib Robert H, Badhwar Vinay. Bioprosthetic vs Mechanical Aortic Valve Replacement in Patients 40 to 75 Years of Age.. Journal of the American College of Cardiology. 2025. DOI: 10.1016/j.jacc.2025.01.013.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.